IMU-366

N/A

Report date: 2022/10/10 16:53:19
NME

Base Information

Drug NameIMU-366
Drug Alias NameIMU-366
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma antagonists
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsAutoimmune DiseasesPsoriasisInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator Companies4sc Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunic Ag
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesPsoriasisInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A